Physician profile
Travis Schaefer
NPI 1881184463
$5,614.57
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.06 · 2020: $118 · 2022: $241 · 2023: $2,407 · 2024: $2,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,500 · Travel and Lodging: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,499.70 |
| Travel and Lodging | $658.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,588.31 | 2023-2024 | Wavewriter Alpha Prime 16, Vercise |
| Abbott Laboratories | $1,083.30 | 2024 | Proclaim, Eterna |
| Nevro Corp. | $733.41 | 2022-2024 | Senza |
| Medtronic, INC. | $543.87 | 2022-2024 | Synchromedii, Intellis Adaptivestim |
| Biotronik Nro, INC. | $440.44 | 2023-2024 | Prospera, Biotronik |
| Spr Therapeutics, INC | $256.32 | 2023 | Sprint Pns System |
| Spinal Simplicity, LLC | $190.61 | 2023-2024 | Ha Minuteman G3-R |
| Mml US, INC. | $175.98 | 2024 | Reactiv8 |
| Vertos Medical, INC. | $159.25 | 2023 | Mild Device Kit |
| Relievant Medsystems, INC. | $107.36 | 2023 | Intracept |
| Nalu Medical, INC. | $95.72 | 2024 | Nalu Neurostimulation System |
| Sanofi-Aventis U.S. LLC | $56.91 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $39.01 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $28.52 | 2020 | |
| Abbvie INC. | $24.53 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.97 | 2019 | |
| Astellas Pharma US INC | $17.33 | 2020 | |
| Genzyme Corporation | $15.68 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.38 | 2019 | |
| Amgen INC. | $13.09 | 2020 | |
| Pfizer INC. | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.